T cells from control healthy donor PBMCs and RCC single-cell suspensions were examined following 5 days in culture to compare single-cell gene expression from T cells treated with IL-7 to maintain viability or stimulated with CD3 alone; CD3 with CD28; or CD3 with CD28 and IL-2 (Figure 3). This evidence concerns the gene IL2 and renal cell carcinoma.